Literature DB >> 1601269

In vitro uterine contractions in the viviparous lizard Tiliqua rugosa: effects of gestation and steroid pretreatment in vivo.

B Fergusson1, S D Bradshaw.   

Abstract

Uterine contractility was investigated in the viviparous lizard Tiliqua rugosa. Arginine vasotocin (AVT) induces rhythmic contractions in vitro in strips of uterine tissue from ovariectomized female T. rugosa. The strength of these contractions was related to the dosage of AVT and reduced by pretreatment in vivo with both progesterone and estradiol-17 beta. The frequency of spontaneous and AVT-induced contractions was enhanced by estradiol-17 beta pretreatment. The strength of AVT-induced contractions in pregnant females was not significantly different from that recorded in nonpregnant females. Spontaneous rhythmic contractions were present only in pregnant females. Ovariectomy did not affect either spontaneous or AVT-induced contractions in pregnant females. The data indicate that ovarian steroids modulate uterine contractility in T. rugosa. It is suggested that, following a decline in plasma progesterone levels, estrogen may be involved in the onset of parturition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601269     DOI: 10.1016/0016-6480(92)90103-q

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  2 in total

1.  A comparison of uterine contractile responsiveness to arginine vasopressin in oviparous and viviparous lizards.

Authors:  Jonathan W Paul; Joshua O Kemsley; Trent A Butler; Jorge M Tolosa; Michael B Thompson; Roger Smith; Camilla M Whittington
Journal:  J Comp Physiol B       Date:  2019-12-19       Impact factor: 2.200

2.  Timing of parturition in two species of viviparous lizard: influences of beta-adrenergic stimulation and temperature upon uterine responses to arginine vasotocin (AVT).

Authors:  Natalia Atkins; Susan M Jones; Louis J Guillette
Journal:  J Comp Physiol B       Date:  2006-07-11       Impact factor: 2.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.